Trade Vor Biopharma Inc. - VOR CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.024346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.002124% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 0.94 |
| Open | 0.95 |
| 1-Year Change | -57.4% |
| Day's Range | 0.93 - 0.96 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Dec 17, 2024 | 0.94 | -0.05 | -5.05% | 0.99 | 0.99 | 0.93 |
| Dec 16, 2024 | 0.99 | 0.02 | 2.06% | 0.97 | 0.99 | 0.94 |
| Dec 13, 2024 | 0.96 | -0.01 | -1.03% | 0.97 | 0.97 | 0.93 |
| Dec 12, 2024 | 0.94 | -0.03 | -3.09% | 0.97 | 0.99 | 0.91 |
| Dec 11, 2024 | 0.95 | -0.03 | -3.06% | 0.98 | 1.02 | 0.92 |
| Dec 10, 2024 | 0.98 | -0.05 | -4.85% | 1.03 | 1.03 | 0.89 |
| Dec 9, 2024 | 1.01 | 0.15 | 17.44% | 0.86 | 1.07 | 0.85 |
| Dec 6, 2024 | 0.79 | -0.04 | -4.82% | 0.83 | 0.84 | 0.78 |
| Dec 5, 2024 | 0.82 | -0.06 | -6.82% | 0.88 | 0.88 | 0.81 |
| Dec 4, 2024 | 0.87 | -0.06 | -6.45% | 0.93 | 0.93 | 0.85 |
| Dec 3, 2024 | 0.87 | 0.01 | 1.16% | 0.86 | 0.88 | 0.83 |
| Dec 2, 2024 | 0.84 | 0.01 | 1.20% | 0.83 | 0.87 | 0.81 |
| Nov 29, 2024 | 0.79 | 0.01 | 1.28% | 0.78 | 0.81 | 0.77 |
| Nov 27, 2024 | 0.77 | -0.01 | -1.28% | 0.78 | 0.78 | 0.74 |
| Nov 26, 2024 | 0.77 | -0.03 | -3.75% | 0.80 | 0.80 | 0.75 |
| Nov 25, 2024 | 0.80 | 0.01 | 1.27% | 0.79 | 0.82 | 0.78 |
| Nov 22, 2024 | 0.77 | 0.01 | 1.32% | 0.76 | 0.78 | 0.75 |
| Nov 21, 2024 | 0.77 | -0.01 | -1.28% | 0.78 | 0.78 | 0.73 |
| Nov 20, 2024 | 0.76 | 0.02 | 2.70% | 0.74 | 0.79 | 0.73 |
| Nov 19, 2024 | 0.74 | -0.02 | -2.63% | 0.76 | 0.76 | 0.70 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Vor Biopharma Inc. Company profile
About Vor Biopharma Inc
Vor Biopharma Inc is a clinical-stage cell therapy company. The Company is engaged in combining a novel patient engineering approach with targeted therapies to provide solution for patients suffering from hematological malignancies. The Company develops engineered hematopoietic stem cell (eHSC) product candidate, VOR33, VCAR33, which together are the treatment paradigm for acute myeloid leukemia (AML) and other hematological malignancies. The Company’s platform provides treatment for both hematopoietic stem cell transplants and targeted therapies, such as antibody drug conjugates (ADCs), bispecific antibodies and CAR-T cell treatments, including CD33 CAR-T. The Company uses genome engineering technology to remove CD33 surface targets from hematopoietic stem cells (HSCs) to create VOR33. The Company’s eHSCs, such as VOR33, are designed to be used with therapeutics such as VCAR33, that would provide tumor-specific killing.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Vor Biopharma Inc revenues was not reported. Net loss applicable to common stockholders increased 65% to $51.9M. Higher net loss reflects Research and development - Balancing val increase of 67% to $33.2M (expense), General and administrative - Balancing increase from $7M to $14.4M (expense), Stock-based Compensation in R&D increase from $374K to $1.6M (expense).
| Industry: | Biotechnology & Medical Research (NEC) |
100 Cambridgepark Drive
Suite 101
CAMBRIDGE
MASSACHUSETTS 02140
US
News
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
22:39, 12 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
12:47, 5 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com